42nd week of 2019 patent applcation highlights part 9 |
Patent application number | Title | Published |
20190314368 | ORAL SOLID PREPARATION AND USE THEREOF | 2019-10-17 |
20190314369 | Methods of Treating Cancers, Immune and Autoimmune Diseases, and Inflammatory Diseases Based on BTK Occupancy and BTK Resynthesis Rate | 2019-10-17 |
20190314370 | Arylamide compounds and compositions and uses thereof | 2019-10-17 |
20190314371 | USE OF MODULATORS OF CCR5 IN THE TREATMENT OF CANCER AND CANCER METASTASIS | 2019-10-17 |
20190314372 | PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS | 2019-10-17 |
20190314373 | AZA-PYRIDONE COMPOUNDS AND USES THEREOF | 2019-10-17 |
20190314374 | CALMODULIN INHIBITORS, CHK2 INHIBITORS AND RSK INHIBITORS FOR THE TREATMENT OF RIBOSOMAL DISORDERS AND RIBOSOMAPATHIES | 2019-10-17 |
20190314375 | IDENTIFICATION OF GRANINS AS THE PATHOGENIC FACTOR OF ALZHEIMER'S DISEASE AND COMPOSITIONS AND METHODS FOR INHIBITING GRANIN AGGREGATION AND TREATING ALZHEIMER'S DISEASE | 2019-10-17 |
20190314376 | FATTY ACID SYNTHASE INHIBITORS | 2019-10-17 |
20190314377 | TREATMENT OF HEMATOLOGICAL MALIGNANCY WITH SMALL MOLECULE NF-KB INHIBITORS | 2019-10-17 |
20190314378 | Gene Therapy For Mesothelioma | 2019-10-17 |
20190314380 | DACTINOMYCIN COMPOSITIONS AND METHODS FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA | 2019-10-17 |
20190314381 | COMPOSITIONS AND METHODS FOR INHIBITION OF MYCOBACTERIA | 2019-10-17 |
20190314382 | COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES | 2019-10-17 |
20190314383 | COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION | 2019-10-17 |
20190314384 | METHODS FOR TREATING GI TRACT DISORDERS | 2019-10-17 |
20190314385 | Process for Preparation of Chlorpromazine or its Pharmaceutically Acceptable Salts | 2019-10-17 |
20190314386 | NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES | 2019-10-17 |
20190314387 | COMPOSITIONS AND METHODS OF TREATING LIVER DISEASE | 2019-10-17 |
20190314388 | PHARMACEUTICAL COMPOSITION CONTAINING DEOXYCHOLIC ACID | 2019-10-17 |
20190314389 | COMPOSITIONS COMPRISING TRITERPENOIDS | 2019-10-17 |
20190314390 | EP4 INHIBITORS AND USE THEREOF | 2019-10-17 |
20190314391 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | 2019-10-17 |
20190314392 | (R)-3-((3S,4S)-3-FLUORO-4-(4-HYDROXYPHENYL)PIPERIDIN-1-YL)-1-(4-METHYLBENZ- YL)PYRROLIDIN-2-ONE AND ITS PRODRUGS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS | 2019-10-17 |
20190314393 | COMPOSITION AND USES THEREOF | 2019-10-17 |
20190314394 | IMMUNE-POTENTIATING DRUG NANOCARRIERS AND METHODS OF PRODUCTION AND USE THEREOF | 2019-10-17 |
20190314395 | USE OF COMPOUNDS ACTIVATING SIRT-3 FOR MIMICKING EXERCISE | 2019-10-17 |
20190314396 | DOSAGE REGIMEN FOR SAPACITABINE AND DECITABINE IN COMBINATION FOR TREATING ACUTE MYELOID LEUKEMIA | 2019-10-17 |
20190314397 | Methods For Directed Folding Assembly Or Dimerization Of Proteins By Templated Assembly Reactions | 2019-10-17 |
20190314398 | MEANS FOR MODULATING GENE EXPRESSION | 2019-10-17 |
20190314399 | Estrogen Sensing Through GPER1 Regulates Normal and Malignant Liver Growth | 2019-10-17 |
20190314400 | VEHICLE FOR DELIVERING A COMPOUND TO A MUCOUS MEMBRANE AND RELATED COMPOSITIONS, METHODS AND SYSTEMS | 2019-10-17 |
20190314401 | ANTISENSE-OLIGONUCLEOTIDES AS INHIBITORS OF TGF-R SIGNALING | 2019-10-17 |
20190314402 | ORAL COMPOSITIONS FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX | 2019-10-17 |
20190314403 | COMPOSITIONS AND METHODS FOR TREATING ELASTIC FIBER BREAKDOWN | 2019-10-17 |
20190314404 | METHOD OF PRODUCING PHYSIOLOGICAL AND THERAPEUTIC LEVELS OF NITRIC OXIDE THROUGH AN ORAL DELIVERY SYSTEM | 2019-10-17 |
20190314405 | ARTICLE OF APPAREL | 2019-10-17 |
20190314406 | TRANSDERMAL MAGNESIUM CREAM COMPOSITIONS | 2019-10-17 |
20190314407 | COMPOSITIONS AND METHODS FOR THE EXPANSION OF HEMATOPOIETIC STEM AND PROGENITOR CELLS | 2019-10-17 |
20190314408 | USE OF SOMATIC STEM CELLS FOR REDUCING IL-6 LEVEL | 2019-10-17 |
20190314409 | CANCER-KILLING CELLS | 2019-10-17 |
20190314410 | CHIMERIC RECEPTOR T CELL TREATMENT USING CHARACTERISTICS OF THE TUMOR MICROENVIRONMENT | 2019-10-17 |
20190314411 | Modified Cell Expansion and Uses Thereof | 2019-10-17 |
20190314412 | METHODS AND COMPOSITIONS HIGH SCALE THERAPEUTIC PRODUCTION OF MEMORY NK CELLS | 2019-10-17 |
20190314413 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2019-10-17 |
20190314414 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | 2019-10-17 |
20190314415 | RAR SELECTIVE AGONISTS IN COMBINATION WITH IMMUNE MODULATORS FOR CANCER IMMUNOTHERAPY | 2019-10-17 |
20190314416 | METHODS FOR PROMOTING HEALING OF TISSUE | 2019-10-17 |
20190314417 | IMMUNOSUPPRESSIVE MESENCHYMAL CELLS AND METHODS FOR FORMING SAME | 2019-10-17 |
20190314418 | COMPOSITIONS AND METHODS FOR INHIBITION OF LINEAGE SPECIFIC ANTIGENS | 2019-10-17 |
20190314419 | COMPOSITION CONTAINING ADIPOSE STEM CELL-DERIVED EXOSOMES AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING LIVER FIBROSIS | 2019-10-17 |
20190314420 | BONE DERIVED FIBERS AND OXYGENATED WOUND TREATMENTS | 2019-10-17 |
20190314421 | NUCLEIC ACID CONSTRUCTS INCLUDING A TXNIP PROMOTER FOR THE TREATMENT OF DISEASE | 2019-10-17 |
20190314422 | MAMMALIAN BIRTH TISSUE COMPOSITION FOR TUMOR TREATMENT | 2019-10-17 |
20190314423 | PLACENTAL MESENCHYMAL STEM CELLS, METHODS OF PRODUCTION, AND PLACENTAL MESENCHYMAL STEM CELL BASED THERAPEUTICS | 2019-10-17 |
20190314424 | TREATMENT OF LYMPHEDEMA AND RELATED CONDITIONS USING PLACENTAL ADHERENT CELLS | 2019-10-17 |
20190314425 | AKKERMANSIA MUCINIPHILA STRAIN HAVING A PROPHYLACTIC OR THERAPEUTIC EFFECT ON A DEGENERATIVE BRAIN DISEASE OR METABOLIC DISEASE AND USE THEREOF | 2019-10-17 |
20190314426 | HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS | 2019-10-17 |
20190314427 | METHODS OF TREATING CANCER USING PARABACTEROIDES | 2019-10-17 |
20190314428 | METHODS AND COMPOSITIONS FOR CHANGING THE COMPOSITION OF THE SKIN MICROBIOME USING COMPLEX MIXTURES OF BACTERIAL STRAINS | 2019-10-17 |
20190314429 | Cancer Treatment and Diagnosis | 2019-10-17 |
20190314430 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF AUTOSOMAL RECESSIVE CONGENITAL ICHTHYOSIS | 2019-10-17 |
20190314431 | Method of Discovery of Potential Bioactive Compounds in Herbals by Regrouping after Chromatography | 2019-10-17 |
20190314432 | METHOD FOR EXTRACTION OF AN AGENT FROM A PLANT SOURCE | 2019-10-17 |
20190314433 | Composition for the Prevention and/or Treatment of Cardiovascular Diseases | 2019-10-17 |
20190314434 | METHOD FOR PREPARING NON-TOXIC LACQUER, FERMENTED RICE BRAN POWDER USING SAME, AND METHOD FOR MANUFACTURING POWDERED GRAIN NUTRIENT FOOD | 2019-10-17 |
20190314435 | METHOD OF TREATING OR REDUCING THE SEVERITY OF DERMATOLOGICAL CONDITIONS | 2019-10-17 |
20190314436 | PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF LIVER CANCER AND HEALTH FUNCTIONAL FOOD | 2019-10-17 |
20190314437 | COMPOSITION CONTAINING DOLICHOS LABLAB LINN. EXTRACT AS ACTIVE INGREDIENT FOR EASING HANGOVERS, AND PREVENTING, ALLEVIATING OR TREATING ALCOHOLIC GASTROINTESTINAL DISEASES | 2019-10-17 |
20190314438 | ORGANIC EYE DROPS | 2019-10-17 |
20190314439 | METHOD FOR SUPPRESSING OBESITY OR DEVELOPMENT OF OBESITY | 2019-10-17 |
20190314440 | COMPOSITION FOR PREVENTING OR TREATING DISEASES CAUSED BY CAFFEINE ABUSE INCLUDING EVODIA OFFICINALIS EXTRACT OR EVODIAMINE AS ACTIVE INGREDIENT | 2019-10-17 |
20190314441 | Method For The Management Of Cancer And Cancer Treatment-Related Comorbidities | 2019-10-17 |
20190314442 | COMPOSITION FOR THE PREVENTION OR TREATMENT OF NEURODEGENERATIVE DISEASES | 2019-10-17 |
20190314443 | COMPOSITION FOR SUPPRESSING MUSCULAR ATROPHY | 2019-10-17 |
20190314444 | ETBR ANTAGONIST COMPOUNDS, COMPOSITIONS, AND USES | 2019-10-17 |
20190314445 | ACTIVATION AND EXPANSION OF NKG2C+ NK CELLS | 2019-10-17 |
20190314446 | VAP POLYPEPTIDE AND USE THEREOF IN PREPARATION OF DRUG FOR TARGETED DIAGNOSIS AND TREATMENT OF TUMOR | 2019-10-17 |
20190314447 | D-ENANTIOMERIC PEPTIDES FOR THE THERAPY OF CHRONIC AND NEUROPATHIC PAIN | 2019-10-17 |
20190314448 | TREATMENT OF DEGENERATIVE JOINT DISEASE | 2019-10-17 |
20190314449 | CYCLIC DIPEPTIDES AND WOUND HEALING | 2019-10-17 |
20190314450 | METHOD AND KIT FOR BOWEL PREPARATION | 2019-10-17 |
20190314451 | COMPOSITION IN POWDER FORM COMPRISING IRON-MILK PROTEIN COMPLEXES AND PROBIOTIC BACTERIA | 2019-10-17 |
20190314452 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING HEPATITIS, HEPATIC FIBROSIS, AND HEPATIC CIRRHOSIS COMPRISING FUSION PROTEINS | 2019-10-17 |
20190314453 | PEPTIDE FOR REPAIRING CARTILAGE AND TREATING OSTEOARTHRITIS | 2019-10-17 |
20190314454 | Composition and Methods for the Treatment of Degenerative Retinal Conditions | 2019-10-17 |
20190314455 | CYTOKINE CONJUGATES FOR THE TREATMENT OF PROLIFERATIVE AND INFECTIOUS DISEASES | 2019-10-17 |
20190314456 | METHODS OF USING INTERLEUKIN-10 FOR TREATING DISEASES AND DISORDERS | 2019-10-17 |
20190314457 | METHODS OF TREATING ALCOHOL ABUSE DISORDER | 2019-10-17 |
20190314458 | METHODS OF TREATING HORMONAL DISORDERS ASSOCIATED WITH ANDROGEN DEFICIENCY USING A REPEAT MICROFLARE DOSING REGIMEN | 2019-10-17 |
20190314459 | TREATMENT OF HORMONAL DISORDERS OF GROWTH | 2019-10-17 |
20190314460 | OVOTRANSFERRIN TREATMENT FOR THE REPRODUCTIVE TRACT | 2019-10-17 |
20190314461 | COMPOSITION AND METHOD FOR TREATING NUCLEIC ACID-RELATED EYE DISEASE | 2019-10-17 |
20190314462 | NOROVIRUS DEACTIVATOR AND METHOD FOR PRODUCING SAME, METHOD FOR DEACTIVATING NOROVIRUS, METHOD FOR PRODUCING LYSOZYME COMPONENT FOR NOROVIRUS DEACTIVATION USE, PROPHYLACTIC OR THERAPEUTIC AGENT FOR NOROVIRUS INFECTION, AND EXTERNAL PREPARATION FOR SKIN FOR NOROVIRUS DEACTIVATION PURPOSES | 2019-10-17 |
20190314463 | METHOD FOR MAKING GLUCAGON AND INSULIN RESTORE NORMAL BALANCE | 2019-10-17 |
20190314464 | NOVEL METHOD FOR TREATING DIABETES | 2019-10-17 |
20190314465 | METHOD FOR PROMOTING INSULIN SECRETION | 2019-10-17 |
20190314466 | METHOD FOR PREVENTING AND TREATING SKIN FIBROSIS | 2019-10-17 |
20190314467 | METHOD FOR PREVENTING AND TREATING LIVER FIBROSIS | 2019-10-17 |
20190314468 | METHOD FOR PREVENTING AND TREATING PULMONARY FIBROSIS | 2019-10-17 |